A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Dual CEA/CD44 targeting to colorectal cancer cells using nanobodies-conjugated hyaluronic acid-modified mesoporous silica nanoparticles with pH- and redox-sensitivity
2022
Materials Advances
Colorectal cancer (CRC) is the second leading cause of cancer death among all malignancies. Drug delivery targeting tumor surface receptors improves therapeutic effects and lowers side-effects since it can increase...
doi:10.1039/d2ma00082b
fatcat:vs4sccf4hjgsxf2hldyl6oezdq